Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056899 · ClinicalTrials.gov registry record · Phase 1
Maintenance Gabapentin to Prolong Pregnancy.
A Phase 1 study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT02056899: Completed Phase 1 study, sponsored by State University of New York at Buffalo.
NCT02056899 is a Phase 1 study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 4 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02056899, a Phase 1 study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the tolerability and effects of maintenance gabapentin therapy on the rate of premature birth in women who have had preterm labor.
Interventions
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
What the finished NCT02056899 record still lists
NCT02056899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Gabapentin is the first listed.
NCT02056899 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02056899 about?
NCT02056899 is a clinical study titled "Maintenance Gabapentin to Prolong Pregnancy.". This is a pilot study to evaluate the tolerability and effects of maintenance gabapentin therapy on the rate of premature birth in women who have had preterm labor.
What is the current status of trial NCT02056899?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2013-06. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02056899?
The interventions under investigation include: Gabapentin (DRUG).
Who is sponsoring clinical trial NCT02056899?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02056899's enrollment target sits among peer trials
4 1995th of 2000 higher than 2 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia